Molina Healthcare Inc. Lobbying Disclosure: $240,000 Spent in Q2 2025

Molina Healthcare Inc. spent $240,000 on lobbying in Q2 2025, focusing on issues like Medicare Advantage payment rates, Medicaid payment rates, and Marketplace enhanced tax credits. Congressional members have traded MOH stock four times in the past six months, with some purchasing and selling shares. Insiders have made nine trades, with the CEO selling 87,500 shares for $28,005,170. Institutional investors have made significant changes to their MOH holdings, with some adding and others removing shares.

Molina Healthcare Inc. (NYSE: MOH) disclosed spending $240,000 on lobbying activities during the second quarter of 2025, according to a new Lobbying Disclosure Act filing [1]. The company focused its lobbying efforts on issues related to Medicare Advantage payment rates and policies, Medicaid payment rates and policies, and Marketplace enhanced tax credits.

In addition to its lobbying activities, Molina Healthcare has seen significant trading activity in its stock over the past six months. Congressional members have traded MOH stock four times, with two purchases and two sales. Representative Gilbert Ray Cisneros, Jr. made one purchase worth up to $15,000 on April 29 and one sale worth up to $15,000 on May 30. Representative Robert Bresnahan also made one purchase worth up to $15,000 on May 15 and one sale worth up to $15,000 on January 13 [1].

Insiders at Molina Healthcare have also been active in trading the company's stock. The CEO, Joseph M. Zubretsky, sold 87,500 shares for an estimated $28,005,170, while Steven J. Orlando and Dale B. Wolf sold smaller amounts of shares [1]. Institutional investors have also made significant changes to their MOH holdings. Robeco Institutional Asset Management B.V. bought 3,247 shares valued at approximately $1,070,000 in the first quarter, while US Bancorp DE increased its stake by 22.3% in the fourth quarter, purchasing an additional 364 shares [2, 3].

These trading activities and lobbying efforts highlight the ongoing interest in Molina Healthcare's stock and the company's strategic initiatives. As the healthcare sector continues to evolve, investors should closely monitor these developments and the broader market conditions impacting the company.

References:
[1] https://www.quiverquant.com/news/Lobbying+Update%3A+%24240%2C000+of+MOLINA+HEALTHCARE+INC.+lobbying+was+just+disclosed
[2] https://www.marketbeat.com/instant-alerts/filing-robeco-institutional-asset-management-bv-purchases-shares-of-3247-molina-healthcare-inc-nysemoh-2025-07-03/
[3] https://www.ainvest.com/news/molina-healthcare-q2-2025-earnings-surprise-navigating-term-challenges-long-term-medicaid-medicare-growth-2507/